Whitepaper: Generative AI in the life sciences industry

How companies should reorganise themselves in order to use the advantages of GenAI for research and development more efficiently.

Cover of the whitepaper "Generative AI in the life sciences industry"

Generative artificial intelligence (GenAI) is changing the life sciences industry faster than many expected. Drugs are being developed in less time, therapies are being tailored to individual patients and processes are being streamlined by AI agents. But the transformation continues: structures, roles and competences are also fundamentally shifting.

In the white paper "GenAI Unleashed - Catalyzing Innovation in the Life Sciences Industry", you will learn how companies are making the step from individual projects to real transformation. Using current examples and data, it shows where the industry stands and how organisations should position themselves now in order to remain competitive.

Learn how to:

  • define new role profiles that combine management and technology,

  • prepare teams for the future with targeted GenAI skills and

  • create agile structures that allow humans and machines to interact productively.